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DBackground: Despite medical treatment, one third of patients with uncomplicated type B aortic dissections
experience severe late complications. The aim of this study was to identify patients at high risk of mortality
during follow-up.
Methods: A total of 183 patients with acute Stanford type B dissection were treated in one of the university
hospitals (Aachen [Germany], Maastricht [The Netherlands], and Innsbruck [Austria]) between 1997 and
2010. Records indicated that 120 patients were treated conservatively. Of these patients, 16 were lost to
follow-up. The maximum diameter, extent of the dissection, and patency of the side branches were determined
from computed tomography angiography data. Survival and treatment failure were analyzed by univariate and
multivariate Cox regression analysis. The univariate analysis investigated the influence of aortic diameter (41
vs<41 mm) on survival, and the multivariate analysis investigated the influence of aortic diameter, age, sex, and
surgery on survival.
Results: During the follow-up period, the initial treatment was converted to surgical treatment in 21 patients
(20.2%). Sixteen of the 104 patients (15.4%) died after a mean of 845.5 805.9 days. Themeanmaximum aortic
transversal diameter at admission was 41.2  8.7 mm. The multivariate analysis identified aortic diameter
(P¼ .004; hazard ratio, 1.07) and age (P¼ .038; hazard ratio, 1.05) as risk factors that significantly reduce survival.
Conclusions:Our study revealed both early aortic dilatation and older age as risk factors for increased mortality
after conservative treatment of type B dissection. (J Thorac Cardiovasc Surg 2014;148:2155-60)Supplemental material is available online.Despite medical treatment, one third of patients with type B
aortic dissection have life-threatening complications,
including death, rupture, increasing aortic diameter, and
visceral or lower-limb ischemia, over the courseof 5years.1,2
Data from the International Registry of Aortic Dissection
(IRAD) reveal high mortality, with 1 in 4 patients dying
within 3 years after acute type B dissection. After
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The Journal of Thoracic and Carby dissection-associated complications, such as rupture or
perioperative mortality from aortic repairs.3-8
The current criteria for primary surgical or endovascular
repair of type B dissections include primarily life-
threatening scenarios, such as rupture, malperfusion
syndrome, progression of the dissection, enlarging
aneurysms, and an inability to control blood pressure
or symptoms.7,9-12 The theoretic aim for thoracic
endovascular aortic repair (TEVAR) in acute type B
dissection is to remodel the architecture of the aortic wall
by covering the proximal entry tear of the dissection and
reexpanding the true lumen, thereby excluding the false
lumen. Prophylactic TEVAR in uncomplicated type B
dissections should prevent complications, particularly
aneurysm enlargement. The first randomized study of
elective stent-graft placement in survivors of uncomplicated
type B aortic dissection, the INvestigation of STEnt grafts in
patients with type B Aortic Dissections (INSTEAD) trial,
did not reveal a difference in the 2-year cumulative survival
between optimal medical therapy and TEVAR.2 In
contrast to these results after 2 years, the long-term
results displayed an improved survival after TEVAR.13
However, conservative treatment is still recommended for
uncomplicated type B aortic dissection.11,14
However, the current therapeutic strategy of waiting until
the criteria for surgical or endovascular repair are metdiovascular Surgery c Volume 148, Number 5 2155
Abbreviations and Acronyms
CTA ¼ computed tomography angiography
HR ¼ hazard ratio
INSTEAD ¼ INvestigation of STEnt grafts in
patients with type BAortic Dissections
IQR ¼ interquartile range
IRAD ¼ International Registry of Aortic
Dissection
TEVAR ¼ thoracic endovascular aortic repair
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D seems to endanger some patients. In particular, patients with
evolving transversal aortic enlargement are confronted with
perioperative mortality and morbidity from subsequent
aortic repairs or jeopardized by a substantial risk of
rupture.3,5,7,15 The aim of this study was to analyze the
course of uncomplicated, conservatively treated type B
dissections to identify patients with increased mortality
during follow-up.
METHODS
Patients and Treatment
Between January 1997 and February 2010, 183 patients with an acute
Stanford type B dissection as confirmed by multidetector computed
tomography angiography (CTA) were admitted to 1 of 3 university
hospitals in 3 specific centers. Among these patients, 63 (34%) had
evidence of complications, such as rupture, excessive aortic enlargement,
or visceral, renal, or extremity ischemia, and were referred for surgical
or endovascular repair. Patients with uncomplicated type B dissection
(n ¼ 120, 66%) were admitted to the critical care unit, where their blood
pressure was monitored and adjusted by optimal medical therapy (systolic
arterial pressure <120 mm Hg) including a tailored antihypertensive
regimen. Patients were switched to oral administration as soon as possible
and closely observed for evidence of extremity, visceral, or renal
malperfusion. Pain was treated according to World Health Organization
guidelines. After discharge, the patients continued to receive oral
antihypertensive therapy. CTA was performed at the time of diagnosis
and repeated before discharge or in the case of complications. During
follow-up, control computed tomography scans were performed after 3,
6, and 12 months and thereafter annually. The CTA data were analyzed
by 2 independent investigators with regard to the maximum axial diameter
of the aorta, extension of the dissection, and patency or thrombosis of the
true lumen and the side branches. Among the patients who received initial
medical treatment, 16 were lost to follow-up. This retrospective data
analysis was performed according to our local ethics committee, and the
data of 104 patients, including comorbidity and morphologic data, were
reviewed.
Statistical Analysis
Continuous variables are expressed as mean values standard deviation
or median and interquartile range (IQR). This article constitutes 2 time-to-
event end points. The first time-to-event end point is ‘‘death,’’ reflecting a
classic survival setting. In addition, the time-to-event end point ‘‘treatment
failure’’ was investigated. Treatment failurewas defined as death or surgery
after conservative treatment. Both end points were analyzed descriptively
using Kaplan–Meier estimates, illustrated by the corresponding curves in
Figures 1 and 2, and inferentially by univariate and multivariate Cox
regression analysis. First, univariate Cox regression analysis was
performed to investigate the influence of diameter (41 vs<41 mm) on2156 The Journal of Thoracic and Cardiovascular Surboth end points. Multivariate analysis was then performed to investigate
the influence of diameter, age, gender, and, in case of survival, surgery.
For the latter, after establishing a high-risk category (aortic diameter
41 mm and age 66 years), multivariate Cox regression analysis was
performed to investigate the influence of this factor, gender, and surgery
on survival. In all multivariate Cox regressions on survival, surgery was
modeled as a time-dependent risk factor because of its change over time
for a subset of the study cohort. The significance level was set at
a ¼ 0.05. All Cox regression analyses were performed using SAS version
9.2 (SAS Institute Inc, Cary, NC). Kaplan–Meier estimates and graphs
were created using R (R Version 2.11.1, 2010, The R Foundation for
Statistical Computing).RESULTS
Patient Characteristics
In the 120 patients with a mean age of 65.98 11.2 years
(range, 29-87 years) included in the database, the onset of
symptoms was clearly assessable within the 14 days
preceding admission and typical of aortic dissection.
Diagnosis was established on the basis of computed
tomography within 14 days of the onset of pain. At the
time of the initial diagnosis, all patients were considered
for medical treatment. Sixteen of these 120 patients were
lost during follow-up. The study group included 74 men
(70.8%) and 30 women (29.2%), and the comorbidities
were diabetes in 7 of 104 patients, hypertension in 90 of
104 patients, coronary artery disease in 30 of 104 patients,
renal insufficiency in 15 of 104 patients, smoking in
33 of 104 patients, and connective tissue disease in 3
of 104 patients. Three patients had an acute dissection
superimposed on chronic aneurysms.Conversion to Invasive Therapy
During the follow-up period, the initial medical treatment
was converted to surgical treatment in 21 patients (20.2%)
after a median of 333 days (IQR, 578 days; lower [25%]
quartile value, 125 days; upper [75%] quartile value, 703
days; range, 1-1656 days) (mean, 488.7  514.4 days). In
5 patients (4.8%), endovascular surgery was performed
during the acute dissection phase (within 14 days) because
of acute complications, despite the best medical treatment.
Reasons for TEVAR were rapid extension of the transversal
aortic diameter within 14 days (n¼ 2; 1 man aged 58 years,
1 woman aged 57 years), aortic rupture after 5 and 9 days
(n ¼ 2 men aged 78 and 63 years), and renal ischemia
(n ¼ 1 man aged 67 years). One of these 5 patients, a
63-year-old man, died of aortic rupture and subsequent
hemodynamic shock 5 days after TEVAR.
In 16 patients (15.4%; 10 women), surgery was
performed after a median of 189 days (IQR, 535.5 days;
lower [25%] quartile value, 105.5 days; upper [75%]
quartile value, 641 days; range, 1-1586 days) (mean,
631.8  499.4 days). Surgical treatment was indicated
because of aortic enlargement (n ¼ 14), rupture (n ¼ 1),
or lower-limb ischemia (n ¼ 1) (Table E1). Surgerygery c November 2014
FIGURE 1. Survival. A, Cumulative all-cause survival. B, Univariate analysis revealed a significant difference in the cumulative survival
between patients with an aortic diameter 41 mm and patients with an aortic diameter<41 mm (P ¼ .012). Kaplan–Meier estimates are presented in
Table 1. C, Survival stratified by diameter and age. D, Multivariate Cox regression analysis.
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(n¼ 1), open repair of the infrarenal aorta (n¼ 2), Crawford
type I repair (n ¼ 2), type II repair (n ¼ 6), type III repair
(n ¼ 1), and hybrid procedures (n ¼ 2).
Diameter of Dissection
The mean maximum aortic transverse diameter on
admission was 41.2  8.7 mm. Two patient groups were
created using the median of 41 mm as a cutoff, resulting
in a group with a diameter less than 41 mm (n ¼ 51) and
a group with a diameter of 41 mm or more (n ¼ 53).
Mortality
Sixteen patients (15.4%) died after a median of 774 days
(IQR, 1252 days; lower [25%] quartile value, 38.5 days;
upper [75%] quartile value, 1291 days; range, 2-2805
days) (mean, 826.6  819.1 days). Two patients
(both men) died of aortic rupture during the acute phase
of dissection, despite the best medical treatment. One ofThe Journal of Thoracic and Carthese patients (aged 80 years) died 2 days after the
dissection event. The other patient was aged 63 years; he
sustained an aortic rupture 9 days after the initial dissection
and was referred for emergency TEVAR. Five days after
TEVAR, the patient died as a consequence of hemodynamic
shock as noted earlier. Of the 14 patients who died during
the chronic phase of dissection, 2 died of causes that were
not dissection related. In 6 patients, the cause of death
remains unknown. Therefore, a total of 6 patients died of
dissection-related causes (rupture n¼ 4; intestinal ischemia
n ¼ 1; rupture after TEVAR ¼ 1).
The cumulative all-cause survival at 1, 3, and 6 years was
89.6% (3.2), 78.3% (5.1), and 67.7% (7.3),
respectively (Figure 1, A). Univariate analysis revealed a
significant difference in the cumulative survival between
the 2 diameter groups (P ¼ .012, Figure 1, B and Table 1)
with a hazard ratio (HR) of 4.44 for a diameter of 41 mm
or greater. The multivariate analysis identified aortic diam-
eter (P ¼ .004; HR, 1.07) and age (P ¼ .038; HR, 1.05) asdiovascular Surgery c Volume 148, Number 5 2157
FIGURE 2. Treatment failure. A, Overall failure of conservative treatment. B, Failure of treatment stratified by diameter class revealed a significantly
higher rate in patients with an aortic diameter 41 mm (P ¼ .09; HR, 2.93). Kaplan–Meier estimates are presented in Table 2.
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However, the age distribution between the 2 patient cohorts
based on diameter was unequal, with older patients more
likely to have a diameter of 41mm ormore. After correcting
the binary risk factor, the HR for a diameter of 41 mm or
more was 3.36 and not significant (P ¼ .071). Another
risk factor influencing survival was surgical treatment
during the follow-up (Figure 1, D). Identification of
diameter and age as risk factors motivated the formation
of a high-risk patient cohort characterized by an aortic
diameter of 41 mm or more and age 66 years or more.
The cutoff level for age was set at the median of overallTABLE 1. Mortality Kaplan–Meier estimates stratified by diameter
group
Mortality stratified by diameter group
Time (d) No. at risk Survival
Standard
error
Lower
95% CI
Upper
95% CI
Diameter<41 mm
14 42 0.976 0.0235 0.931 1.000
742 22 0.932 0.0488 0.841 1.000
807 20 0.885 0.0649 0.767 1.000
Diameter 41 mm
2 53 0.981 0.0187 0.9452 1.000
23 45 0.959 0.0283 0.9055 1.000
54 44 0.938 0.0350 0.8713 1.000
109 41 0.915 0.0410 0.8378 0.999
261 36 0.889 0.0471 0.8017 0.986
705 27 0.856 0.0557 0.7539 0.973
954 21 0.816 0.0663 0.6954 0.956
956 20 0.775 0.0745 0.6417 0.935
984 19 0.734 0.0809 0.5913 0.911
1610 11 0.667 0.0973 0.5014 0.888
1672 9 0.593 0.1112 0.4108 0.856
1830 6 0.494 0.1293 0.2960 0.825
2805 2 0.247 0.1863 0.0564 1.000
CI, Confidence interval.
2158 The Journal of Thoracic and Cardiovascular Surage values (65.98 years). In regard to death, multivariate
Cox regression analysis revealed a significant (P ¼ .0004)
HR of 6.87. Figure 1, C illustrates the difference in regard
to cumulative survival between the high-risk patient cohort
(group aortic diameter 41 mm and age 66 years) and
the remaining patients (age<66 years or aortic diameter
<41 mm) (Figure 1, C).Treatment Failure
After analysis of death and conversion to invasive
treatment separately, we combined these 2 end points and
addressed treatment failure of conservative treatment.
A total of 32 patients had treatment failure due to death
or conversion to invasive therapy after a median of 382
days (IQR, 883.5 days; lower [25%] quartile value,
70 days; upper [75%] quartile value, 953.5 days; range,
0-2805 days) (mean, 615.4  686.9 days). Similar to the
analysis of mortality, univariate analysis of the aortic
diameter displayed a significant higher rate of treatment
failure for patients with a larger aortic diameter (P ¼ .11;
HR, 1.038). In the diameter groups, an aortic diameter of
41 mm or more led to a significantly higher rate of treatment
failure (P¼ .009; HR, 2.93) (Figure 2 and Table 2). Univar-
iate analysis of gender and older age revealed no significant
influence (gender: P ¼ .116; HR, 0.56; older age: P ¼ .92;
HR, 1.00). The multivariate analysis, including diameter,
gender, and older age, identified female gender (P ¼ .047;
HR, 2.131) and diameter (P¼ .004; HR, 1.05), but not older
age (P ¼ .662; HR, 0.992), as risk factors of treatment
failure. However, the high-risk group (group aortic diameter
41 mm and age 66 years) showed no significant
difference regarding treatment failure.DISCUSSION
This study followed 104 patients with initial uncompli-
cated type B dissections and identified a patient group withgery c November 2014
TABLE 2. Treatment failure Kaplan–Meier estimates stratified by
diameter group
Treatment failure stratified by diameter group
Time (d) No. at risk Survival
Standard
error
Lower
95% CI
Upper
95% CI
Diameter<41 mm
5 46 0.978 0.0215 0.937 1.000
14 41 0.954 0.0316 0.895 1.00
86 37 0.929 0.0399 0.854 1.000
150 33 0.900 0.0476 0.812 0.999
167 32 0.872 0.0538 0.773 0.984
613 24 0.836 0.0626 0.722 0.968
742 19 0.792 0.0732 0.661 0.949
807 17 0.745 0.0824 0.600 0.926
Diameter 41 mm
1 52 0.981 0.0190 0.9441 1.000
2 51 0.962 0.0267 0.9107 1.000
5 48 0.942 0.0328 0.8794 1.000
13 44 0.920 0.0384 0.8479 0.999
23 43 0.899 0.0431 0.8182 0.987
54 42 0.877 0.0470 0.7898 0.975
109 40 0.855 0.0507 0.7615 0.961
125 39 0.833 0.0540 0.7341 0.946
180 38 0.812 0.0568 0.7075 0.931
199 35 0.788 0.0597 0.6795 0.915
333 32 0.764 0.0627 0.6501 0.897
431 28 0.736 0.0662 0.6175 0.878
669 24 0.706 0.0702 0.5808 0.858
681 23 0.675 0.0735 0.5453 0.836
703 22 0.644 0.0763 0.5109 0.813
953 17 0.606 0.0807 0.4673 0.787
954 16 0.569 0.0841 0.4255 0.760
972 15 0.531 0.0866 0.3854 0.731
1215 14 0.493 0.0883 0.3468 0.700
1586 9 0.438 0.0940 0.2877 0.667
1610 8 0.383 0.0969 0.2335 0.629
1656 7 0.329 0.0973 0.1839 0.587
1830 6 0.274 0.0952 0.1384 0.541
2805 2 0.137 0.1079 0.0292 0.641
CI, Confidence interval.
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66 years with a maximum aortic diameter greater than
40 mm at admission had a 6.87-fold higher mortality risk
than younger patients and patients with smaller aortic
diameters. Our findings are in agreement with Onitsuka
and colleagues,16 who examined the long-term outcome
and prognostic predictors related to the development of
complications associated with acute type B aortic dissection
in 66medically treated patients. A substantial differencewas
found in the initial maximum aortic diameter in patients with
dissection-associated complications and patients with no
complications.
Older patients generally take on a higher surgical risk
than younger patients. Thus, if surgical procedures are
required because of complications during the chronicThe Journal of Thoracic and Carcourse of a dissection, age seems to be a significant
predictive risk factor. In their risk prediction model based
on IRAD data, Suzuki and colleagues17 identified
hypotension/shock, absence of chest/back pain, and branch
vessel involvement, but not age (70 years), as independent
predictors of in-hospital death. Furthermore, age 70 years or
more was not an independent predictor of death during
long-term follow-up in another published analysis of
IRAD data.6 In contrast to the IRAD studies, the present
analysis included age as a continuous variable, allowing
more information and identifying it as an independent
predictor of death. Data in the present study suggest that
older patients take advantage of more aggressive therapy
in the initial treatment of uncomplicated dissections to
prevent conditions that necessitated later chronic phase
surgery.
Multivariate analysis showed that later conversion to
an invasive treatment significantly influenced survival.
However, the study design does not allow a valid
comparison between the groups in regard to invasive
treatment. The need for surgical or endovascular treatment
of an initially uncomplicated type B dissection is always an
indicator of dissection-associated complications. Thus,
extremely ill patients underwent operations. Moreover,
invasive therapy carries an inherent risk of mortality,
particularly in older patients; therefore, these patients
have a greater risk compared with patients who do not
require surgery during the course of dissection. Thus,
influencing the course of dissection therapeutically is
important to avoid the development of conditions that
necessitate late surgical treatment. Aortic expansion was
the most common complication leading to surgery in this
study.
Because of morphologic conditions, endovascular or
hybrid treatment was possible in only 6 of the 17 patients.
Despite measures including cerebrospinal fluid drainage,
distal and selective organ perfusion, and monitoring of
motor evoked potentials, open surgery of extensive type B
dissections causes serious surgical trauma and is associated
with a high mortality.18-20
Furthermore, we combined mortality and conversion
with invasive therapy and addressed treatment failure of
conservative treatment of type B dissection. Although
aortic diameter remained a risk factor, older age was
not a significant risk factor in this analysis. However,
the multivariate analysis revealed female gender as
another risk factor for treatment failure of conservative
treatment.
However, the absolute benefit of TEVAR over alternative
treatments for chronic type B dissections remains unclear.21
In the case of acute dissection, several studies have shown
the potential of TEVAR in remodeling acute dissected
descending aortic walls.22-24 Furthermore, the INSTEAD
trial confirmed that aortic remodeling due to TEVARdiovascular Surgery c Volume 148, Number 5 2159
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years compared with medicamentously treated patients, but
this effect had no significant influence on the survival in the
TEVAR group. The 2-year cumulative all-cause survival of
conservatively treated patients in the INSTEAD trial was
88.9% and comparable to our estimate of 87.9% in the
present report.2 In contrast to these results after 2 years,
the results after 5 years revealed a reduction of mortality
by TEVAR,25 which may indicate a promising role of
TEVAR in uncomplicated type B dissection.
CONCLUSIONS
In regard to mortality, the main finding of our study was
the identification of a subgroup of patients at high risk
(aortic diameter 41 mm and age 66 years), who had a
2-year survival of only 68.5%. In contrast, patients who
did not fulfill the high-risk criteria displayed a cumulative
survival of 95.7% after 2 years. Nevertheless, because of
the retrospective, nonrandomized design of this report,
conclusions from this multicenter analysis have to be drawn
cautiously. Uncomplicated type B dissections in patients
aged 66 years or more with a maximum aortic diameter
greater than 41 mm on admission seem to present a higher
risk of mortality. However, further studies are needed to
determine with more certainty whether patients with
uncomplicated type B dissections benefit from prophylactic
TEVAR, particularly in older patients and in cases of early
aortic dilatation.
References
1. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al.
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for
the diagnosis and management of patients with thoracic aortic disease. A Report
of the American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines, American Association for Thoracic Surgery,
American College of Radiology, American Stroke Association, Society of Car-
diovascular Anesthesiologists, Society for Cardiovascular Angiography and In-
terventions, Society of Interventional Radiology, Society of Thoracic
Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol. 2010;55:
e27-129.
2. Nienaber CA, Rousseau H, Eggebrecht H, Kische S, Fattori R, Rehders TC, et al.
Randomized comparison of strategies for type B aortic dissection: the INvestiga-
tion of STEnt Grafts in Aortic Dissection (INSTEAD) trial. Circulation. 2009;
120:2519-28.
3. Bernard Y, Zimmermann H, Chocron S, Litzler JF, Kastler B, Etievent JP, et al.
False lumen patency as a predictor of late outcome in aortic dissection. Am J Car-
diol. 2001;87:1378-82.
4. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for
surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74:
S1877-80.
5. Gysi J, Schaffner T, Mohacsi P, Aeschbacher B, Althaus U, Carrel T. Early and
late outcome of operated and non-operated acute dissection of the descending
aorta. Eur J Cardiothorac Surg. 1997;11:1163-70.2160 The Journal of Thoracic and Cardiovascular Sur6. Tsai TT, Fattori R, Trimarchi S, Isselbacher E, Myrmel T, Evangelista A, et al.
Long-term survival in patients presenting with type B acute aortic dissection: in-
sights from the International Registry of Acute Aortic Dissection. Circulation.
2006;114:2226-31.
7. Umana JP, Lai DT, Mitchell RS, Moore KA, Rodriguez F, Robbins RC, et al. Is
medical therapy still the optimal treatment strategy for patients with acute type B
aortic dissections? J Thorac Cardiovasc Surg. 2002;124:896-910.
8. Jonker FH, Trimarchi S, Muhs BE, Rampoldi V, Montgomery DG, Froehlich JB,
et al. The role of age in complicated acute type B aortic dissection. Ann Thorac
Surg. 2013;96:2129-34.
9. Mehta RH, Bossone E, Evangelista A, O’Gara PT, Smith DE, Cooper JV, et al.
Acute type B aortic dissection in elderly patients: clinical features, outcomes,
and simple risk stratification rule. Ann Thorac Surg. 2004;77:1622-9.
10. Estrera AL, Miller CC III, Safi HJ, Goodrick JS, Keyhani A, Porat EE, et al. Out-
comes of medical management of acute type B aortic dissection. Circulation.
2006;114:I384-9.
11. Hughes GC, Andersen ND, McCann RL. Management of acute type B aortic
dissection. J Thorac Cardiovasc Surg. 2013;145:S202-7.
12. Ehrlich MP, Rousseau H, Heijmen R, Piquet P, Beregi JP, Nienaber CA, et al.
Midterm results after endovascular treatment of acute, complicated type B aortic
dissection: the Talent Thoracic Registry. J Thorac Cardiovasc Surg. 2013;145:
159-65.
13. Bossone E, Pyeritz RE, O’Gara P, Harris KM, Braverman AC, Pape L, et al.
Acute aortic dissection in blacks: insights from the international registry of acute
aortic dissection. Am J Med. 2013;126:909-15.
14. Svensson LG, Kouchoukos NT, Miller DC, Bavaria JE, Coselli JS, Curi MA,
et al. Expert consensus document on the treatment of descending thoracic aortic
disease using endovascular stent-grafts. Ann Thorac Surg. 2008;85:S1-41.
15. Elefteriades JA, Lovoulos CJ, Coady MA, Tellides G, Kopf GS, Rizzo JA.
Management of descending aortic dissection. Ann Thorac Surg. 1999;67:
2002-5; discussion 2014-9.
16. Onitsuka S, Akashi H, Tayama K, Okazaki T, Ishihara K, Hiromatsu S, et al.
Long-term outcome and prognostic predictors of medically treated acute type
B aortic dissections. Ann Thorac Surg. 2004;78:1268-73.
17. Suzuki T, Mehta RH, Ince H, Nagai R, Sakomura Y, Weber F, et al. Clinical pro-
files and outcomes of acute type B aortic dissection in the current era: lessons
from the International Registry of Aortic Dissection (IRAD). Circulation.
2003;108(Suppl 1):II312-7.
18. Jacobs MJ, Mommertz G, Koeppel TA, Langer S, Nijenhuis RJ, Mess WH, et al.
Surgical repair of thoracoabdominal aortic aneurysms. J Cardiovasc Surg (Tor-
ino). 2007;48:49-58.
19. Mommertz G, Langer S, Koeppel TA, Schurink GW,MessWH, JacobsMJ. Brain
and spinal cord protection during simultaneous aortic arch and thoracoabdominal
aneurysm repair. J Vasc Surg. 2009;49:886-92.
20. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286
thoracoabdominal aortic aneurysms. Ann Thorac Surg. 2007;83:S862-4.
21. Thrumurthy SG, Karthikesalingam A, Patterson BO, Holt PJ, Hinchliffe RJ,
Loftus IM, et al. A systematic review of mid-term outcomes of thoracic endovas-
cular repair (TEVAR) of chronic type B aortic dissection. Eur J Vasc Endovasc
Surg. 2011;42:632-47.
22. O’Donnell S, Geotchues A, Beavers F, Akbari C, Lowery R, Elmassry S, et al.
Endovascular management of acute aortic dissections. J Vasc Surg. 2011;54:
1283-9.
23. Duebener LF, Lorenzen P, Richardt G, Misfeld M, Notzold A, Hartmann F, et al.
Emergency endovascular stent-grafting for life-threatening acute type B aortic
dissections. Ann Thorac Surg. 2004;78:1261-7.
24. Rodriguez JA, Olsen DM, Lucas L, Wheatley G, Ramaiah V, Diethrich EB.
Aortic remodeling after endografting of thoracoabdominal aortic dissection.
J Vasc Surg. 2008;47:1188-94.
25. Nienaber CA, Kische S, Rousseau H, Eggebrecht H, Rehders TC, Kundt G, et al.
Endovascular repair of type B aortic dissection: long-term results of the Random-
ized Investigation of Stent Grafts in Aortic Dissection Trial. Circ Cardiovasc
Interv. 2013;6:407-16.gery c November 2014
TABLE E1. Timing of intervention
Cases
Timing of
intervention (d) Kind of intervention
1 125 Type II repair
2 150 TEVAR with carotid subclavian bypass
3 167 Femoro-femoral bypass
4 180 EVAR with crossover bypass
5 199 Type I repair
6 207 TEVAR
7 261 TEVAR
8 431 Type I repair
9 613 TEVAR with carotid subclavian bypass
10 669 Type II repair
11 703 Type II repair
12 956 Type III repair
13 984 Type II repair
14 1215 AAA repair
15 1586 AAA repair
16 1656 Type II repair
AAA, Abdominal aortic aneurysm; EVAR, endovascular aneurysm repair; TEVAR,
thoracic endovascular aneurysm repair.
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